NO311867B1 - Fremgangsmåte for kondisjonering av vannopplöselige stoffer - Google Patents
Fremgangsmåte for kondisjonering av vannopplöselige stoffer Download PDFInfo
- Publication number
- NO311867B1 NO311867B1 NO19933575A NO933575A NO311867B1 NO 311867 B1 NO311867 B1 NO 311867B1 NO 19933575 A NO19933575 A NO 19933575A NO 933575 A NO933575 A NO 933575A NO 311867 B1 NO311867 B1 NO 311867B1
- Authority
- NO
- Norway
- Prior art keywords
- substances
- solvent
- inert gas
- micronized
- conditioning
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims 11
- 239000000126 substance Substances 0.000 title claims 9
- 230000003750 conditioning effect Effects 0.000 title claims 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 6
- 239000002904 solvent Substances 0.000 claims 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims 3
- 239000011261 inert gas Substances 0.000 claims 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 2
- 235000001014 amino acid Nutrition 0.000 claims 2
- 150000001413 amino acids Chemical class 0.000 claims 2
- 230000003266 anti-allergic effect Effects 0.000 claims 2
- 230000001088 anti-asthma Effects 0.000 claims 2
- 239000000924 antiasthmatic agent Substances 0.000 claims 2
- 150000001720 carbohydrates Chemical class 0.000 claims 2
- 235000014633 carbohydrates Nutrition 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 claims 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 claims 1
- HWAXMFYECKQLDX-UHFFFAOYSA-N 5-[[(4-chlorobenzoyl)amino]methyl]thiophene-2-sulfonyl chloride Chemical compound C1=CC(Cl)=CC=C1C(=O)NCC1=CC=C(S(Cl)(=O)=O)S1 HWAXMFYECKQLDX-UHFFFAOYSA-N 0.000 claims 1
- AWRLZJJDHWCYKN-UHFFFAOYSA-N 5-bromo-2-ethoxy-3-nitropyridine Chemical compound CCOC1=NC=C(Br)C=C1[N+]([O-])=O AWRLZJJDHWCYKN-UHFFFAOYSA-N 0.000 claims 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 claims 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims 1
- 229930091371 Fructose Natural products 0.000 claims 1
- 239000005715 Fructose Substances 0.000 claims 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 claims 1
- 229930195725 Mannitol Natural products 0.000 claims 1
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 claims 1
- 229930006000 Sucrose Natural products 0.000 claims 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims 1
- GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 claims 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 claims 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims 1
- 239000000654 additive Substances 0.000 claims 1
- 235000004279 alanine Nutrition 0.000 claims 1
- BNPSSFBOAGDEEL-UHFFFAOYSA-N albuterol sulfate Chemical compound OS(O)(=O)=O.CC(C)(C)NCC(O)C1=CC=C(O)C(CO)=C1.CC(C)(C)NCC(O)C1=CC=C(O)C(CO)=C1 BNPSSFBOAGDEEL-UHFFFAOYSA-N 0.000 claims 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 claims 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 claims 1
- 229960003416 bambuterol hydrochloride Drugs 0.000 claims 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 claims 1
- 229960003237 betaine Drugs 0.000 claims 1
- 229960000265 cromoglicic acid Drugs 0.000 claims 1
- IMZMKUWMOSJXDT-UHFFFAOYSA-N cromoglycic acid Chemical compound O1C(C(O)=O)=CC(=O)C2=C1C=CC=C2OCC(O)COC1=CC=CC2=C1C(=O)C=C(C(O)=O)O2 IMZMKUWMOSJXDT-UHFFFAOYSA-N 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 238000001035 drying Methods 0.000 claims 1
- 229960001037 fenoterol hydrobromide Drugs 0.000 claims 1
- 238000011010 flushing procedure Methods 0.000 claims 1
- 229930182830 galactose Natural products 0.000 claims 1
- 239000008103 glucose Substances 0.000 claims 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 claims 1
- 229960000367 inositol Drugs 0.000 claims 1
- 239000008101 lactose Substances 0.000 claims 1
- 239000000594 mannitol Substances 0.000 claims 1
- 235000010355 mannitol Nutrition 0.000 claims 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims 1
- 229910052757 nitrogen Inorganic materials 0.000 claims 1
- 239000002245 particle Substances 0.000 claims 1
- 239000013557 residual solvent Substances 0.000 claims 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 claims 1
- 239000005720 sucrose Substances 0.000 claims 1
- 229960005105 terbutaline sulfate Drugs 0.000 claims 1
- KFVSLSTULZVNPG-UHFFFAOYSA-N terbutaline sulfate Chemical compound [O-]S([O-])(=O)=O.CC(C)(C)[NH2+]CC(O)C1=CC(O)=CC(O)=C1.CC(C)(C)[NH2+]CC(O)C1=CC(O)=CC(O)=C1 KFVSLSTULZVNPG-UHFFFAOYSA-N 0.000 claims 1
- 229960000351 terfenadine Drugs 0.000 claims 1
- 239000012808 vapor phase Substances 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 1
- 239000000811 xylitol Substances 0.000 claims 1
- 235000010447 xylitol Nutrition 0.000 claims 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims 1
- 229960002675 xylitol Drugs 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Otolaryngology (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Preparation (AREA)
- Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Compounds Of Unknown Constitution (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Detergent Compositions (AREA)
- Hydrogenated Pyridines (AREA)
- Treating Waste Gases (AREA)
- Paper (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Silver Salt Photography Or Processing Solution Therefor (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- General Preparation And Processing Of Foods (AREA)
- Cephalosporin Compounds (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9101090A SE9101090D0 (sv) | 1991-04-11 | 1991-04-11 | Process for conditioning of water-soluble substances |
| PCT/SE1992/000186 WO1992018110A1 (en) | 1991-04-11 | 1992-03-24 | Process for conditioning of water-soluble substances |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO933575D0 NO933575D0 (no) | 1993-10-06 |
| NO933575L NO933575L (no) | 1993-10-06 |
| NO311867B1 true NO311867B1 (no) | 2002-02-11 |
Family
ID=20382434
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO19933575A NO311867B1 (no) | 1991-04-11 | 1993-10-06 | Fremgangsmåte for kondisjonering av vannopplöselige stoffer |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US5562923A (ru) |
| EP (3) | EP0508969A1 (ru) |
| JP (2) | JP3400999B2 (ru) |
| KR (1) | KR100216384B1 (ru) |
| AT (2) | ATE208613T1 (ru) |
| AU (1) | AU662519B2 (ru) |
| BG (1) | BG61474B1 (ru) |
| CA (1) | CA2106975C (ru) |
| CZ (1) | CZ286936B6 (ru) |
| DE (2) | DE69210601T2 (ru) |
| DK (2) | DK0680752T3 (ru) |
| EE (1) | EE02970B1 (ru) |
| ES (2) | ES2168322T3 (ru) |
| FI (1) | FI105388B (ru) |
| GR (1) | GR3020602T3 (ru) |
| HK (1) | HK52497A (ru) |
| HU (1) | HU211116B (ru) |
| IE (1) | IE921144A1 (ru) |
| IS (1) | IS3834A (ru) |
| NO (1) | NO311867B1 (ru) |
| PL (1) | PL168232B1 (ru) |
| PT (1) | PT680752E (ru) |
| RO (1) | RO115779B1 (ru) |
| RU (1) | RU2112507C1 (ru) |
| SE (1) | SE9101090D0 (ru) |
| SG (1) | SG43180A1 (ru) |
| SK (1) | SK280310B6 (ru) |
| WO (1) | WO1992018110A1 (ru) |
Families Citing this family (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9302777D0 (sv) * | 1993-08-27 | 1993-08-27 | Astra Ab | Process for conditioning substances |
| US5874063A (en) * | 1991-04-11 | 1999-02-23 | Astra Aktiebolag | Pharmaceutical formulation |
| US5980949A (en) * | 1994-10-03 | 1999-11-09 | Astra Aktiebolag | Formulation for inhalation |
| US5983956A (en) * | 1994-10-03 | 1999-11-16 | Astra Aktiebolag | Formulation for inhalation |
| AU701042B2 (en) * | 1995-02-28 | 1999-01-21 | Aventisub Llc | Pharmaceutical composition for piperidinoalkanol compounds |
| US5654007A (en) * | 1995-06-07 | 1997-08-05 | Inhale Therapeutic Systems | Methods and system for processing dispersible fine powders |
| GB9526392D0 (en) | 1995-12-22 | 1996-02-21 | Glaxo Group Ltd | Medicaments |
| SE9700133D0 (sv) * | 1997-01-20 | 1997-01-20 | Astra Ab | New formulation |
| SE9700135D0 (sv) * | 1997-01-20 | 1997-01-20 | Astra Ab | New formulation |
| US6495167B2 (en) | 1997-03-20 | 2002-12-17 | Schering Corporation | Preparation of powder agglomerates |
| US6503537B2 (en) | 1997-03-20 | 2003-01-07 | Schering Corporation | Preparation of powder agglomerates |
| CZ295460B6 (cs) * | 1997-03-20 | 2005-08-17 | Schering Corporation | Způsob výroby aglomerátů a jednotková dávka farmakologicky aktivní látky je obsahující |
| JP4344405B2 (ja) * | 1997-08-26 | 2009-10-14 | アベンティス・ファーマスーティカルズ・インコーポレイテッド | ピペリジノアルカノール−鬱血除去剤の組合せ用医薬組成物 |
| US20060165606A1 (en) | 1997-09-29 | 2006-07-27 | Nektar Therapeutics | Pulmonary delivery particles comprising water insoluble or crystalline active agents |
| SK285068B6 (sk) * | 1997-09-29 | 2006-05-04 | Nektar Therapeutics | Práškový prostriedok, mikrosféry, spôsob tvorby časticového prostriedku obsahujúceho perforované mikroštruktúry prostredníctvom sušenia striekaním a spôsob tvorby prášku obsahujúceho perforované mikroštruktúry prostredníctvom sušenia striekaním |
| FI105074B (fi) | 1997-12-31 | 2000-06-15 | Leiras Oy | Farmaseuttisen formulaation valmistusmenetelmä |
| US6287693B1 (en) * | 1998-02-25 | 2001-09-11 | John Claude Savoir | Stable shaped particles of crystalline organic compounds |
| SE9804000D0 (sv) | 1998-11-23 | 1998-11-23 | Astra Ab | New composition of matter |
| GB9826286D0 (en) * | 1998-12-01 | 1999-01-20 | Rhone Poulence Rorer Limited | Process |
| GB9826284D0 (en) | 1998-12-01 | 1999-01-20 | Rhone Poulence Rorer Limited | Process |
| US8722668B2 (en) * | 1998-12-23 | 2014-05-13 | Daryl W. Hochman | Methods and compositions for the treatment of neuropathic pain and neuropsychiatric disorders |
| US6623760B1 (en) | 1999-01-28 | 2003-09-23 | Schering Corporation | Method of preparing particles for agglomeration |
| AR022695A1 (es) * | 1999-01-28 | 2002-09-04 | Schering Corp | PORTADOR SoLIDO PARTICULADO Y MÉTODO PARA PROVEER CONTROL DE LA PARTICULADA PARA LA DISTRIBUCIoN DE TAMANO DE PARTíCULAS Y DE CONTENIDO AMORFO CONVERTIBLE DURANTE SU PREPARACION |
| US7871598B1 (en) | 2000-05-10 | 2011-01-18 | Novartis Ag | Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use |
| US7309707B2 (en) | 2002-03-20 | 2007-12-18 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Crystalline micronisate, process for the manufacture thereof and use thereof for the preparation of a medicament |
| US7244415B2 (en) | 2002-03-28 | 2007-07-17 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | HFA suspension formulations of an anhydrate |
| US20040028746A1 (en) * | 2002-08-06 | 2004-02-12 | Sonke Svenson | Crystalline drug particles prepared using a controlled precipitation (recrystallization) process |
| GB0228826D0 (en) * | 2002-12-11 | 2003-01-15 | Okpala Joseph | Hair technology in creating particles with improved delivery capabilities |
| WO2004087102A2 (en) * | 2003-03-26 | 2004-10-14 | Teva Pharmaceutical Industries Ltd. | A process for preparing a pharmaceutical active ingredient with high specific surface area |
| WO2004110408A2 (en) * | 2003-06-13 | 2004-12-23 | John Claude Savoir | Process for the manufacture of stable shaped particles consisting of estradiol and cholesterol |
| GB0323684D0 (en) | 2003-10-09 | 2003-11-12 | Jagotec Ag | Improvements in or relating to organic compounds |
| BRPI0415579A (pt) * | 2003-10-17 | 2007-01-02 | Du Pont | estrutura em multicamadas, embalagem e processo |
| JP2007520546A (ja) | 2004-02-03 | 2007-07-26 | ケマジス リミティド | モンテルカストナトリウムの安定な非晶質性形態 |
| DE102004048389A1 (de) | 2004-10-01 | 2006-04-06 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Modifizierung von Oberflächen von Laktose als Hilfsstoff zur Verwendung für Pulverinhalativa |
| DE102004048390A1 (de) | 2004-10-01 | 2006-04-06 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Neue Pulverinhalativa auf Basis modifizierter Laktosemischungen als Hilfsstoff |
| US20070286814A1 (en) * | 2006-06-12 | 2007-12-13 | Medispray Laboratories Pvt. Ltd. | Stable aerosol pharmaceutical formulations |
| JP2011506399A (ja) * | 2007-12-13 | 2011-03-03 | ノバルティス アーゲー | 有機化合物 |
| GB0918149D0 (en) | 2009-10-16 | 2009-12-02 | Jagotec Ag | Improved medicinal aerosol formulation |
| WO2011110852A1 (en) | 2010-03-10 | 2011-09-15 | Astrazeneca Ab | Polymorphic forms of 6- [2- (4 -cyanophenyl) - 2h - pyrazol - 3 - yl] - 5 -methyl - 3 - oxo - 4 - (trifluoromethyl - phenyl) 3,4-dihydropyrazine-2-carboxylic acid ethylamide |
| CA2839398A1 (en) | 2011-06-29 | 2013-01-03 | Bayer Intellectual Property Gmbh | Crystalline form of indazolyl amide derivatives for the treatment glucocorticoid receptor mediated disorders |
| CN105188679B (zh) * | 2013-03-15 | 2018-10-16 | 珍珠治疗公司 | 用于微粒晶体材料的状态调节的方法和系统 |
| WO2021219230A1 (en) | 2020-04-30 | 2021-11-04 | Paolo Fiorina | Antiviral treatment |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3978192A (en) * | 1971-09-23 | 1976-08-31 | Sussman Martin V | Method of drawing fibers using a microterraced drawing surface |
| US4405598A (en) * | 1976-01-30 | 1983-09-20 | Fisons, Limited | Composition for treating asthma |
| KR890000664B1 (ko) * | 1981-10-19 | 1989-03-22 | 바리 안소니 뉴우샘 | 미분된 베클로메타손 디프로피오네이트 일수화물의 제조방법 |
| US4476130A (en) * | 1982-09-09 | 1984-10-09 | Riker Laboratories, Inc. | 3-(1H-Tetrazol-5-yl)-4H-pyrimido[2,1-b]benzoxazol-4-one compounds exhibiting anti-allergic activity |
| WO1986007547A1 (en) * | 1985-06-21 | 1986-12-31 | Gerhard Gergely | Process and device for handling processing material and the reaction product manufactured with the aid of the process and/or device |
| IT1204826B (it) * | 1986-03-04 | 1989-03-10 | Chiesi Farma Spa | Composizioni farmaceutiche per inalazione |
| JP3025528B2 (ja) * | 1989-11-24 | 2000-03-27 | ビオヘミー・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング | パンクレアチン製剤 |
| US5145684A (en) * | 1991-01-25 | 1992-09-08 | Sterling Drug Inc. | Surface modified drug nanoparticles |
-
1991
- 1991-04-11 SE SE9101090A patent/SE9101090D0/xx unknown
-
1992
- 1992-03-24 PL PL92301008A patent/PL168232B1/pl unknown
- 1992-03-24 PT PT95111178T patent/PT680752E/pt unknown
- 1992-03-24 CA CA002106975A patent/CA2106975C/en not_active Expired - Lifetime
- 1992-03-24 WO PCT/SE1992/000186 patent/WO1992018110A1/en active IP Right Grant
- 1992-03-24 SG SG1996004975A patent/SG43180A1/en unknown
- 1992-03-24 DK DK95111178T patent/DK0680752T3/da active
- 1992-03-24 EP EP92850062A patent/EP0508969A1/en active Pending
- 1992-03-24 DE DE69210601T patent/DE69210601T2/de not_active Expired - Lifetime
- 1992-03-24 RO RO93-01336A patent/RO115779B1/ro unknown
- 1992-03-24 KR KR1019930703065A patent/KR100216384B1/ko not_active IP Right Cessation
- 1992-03-24 DK DK92907877.2T patent/DK0580648T3/da active
- 1992-03-24 SK SK1088-93A patent/SK280310B6/sk not_active IP Right Cessation
- 1992-03-24 AU AU15347/92A patent/AU662519B2/en not_active Expired
- 1992-03-24 HU HU9302870A patent/HU211116B/hu unknown
- 1992-03-24 DE DE69232207T patent/DE69232207T2/de not_active Expired - Lifetime
- 1992-03-24 CZ CZ19932116A patent/CZ286936B6/cs not_active IP Right Cessation
- 1992-03-24 EP EP95111178A patent/EP0680752B1/en not_active Expired - Lifetime
- 1992-03-24 RU RU93058260A patent/RU2112507C1/ru active
- 1992-03-24 AT AT95111178T patent/ATE208613T1/de active
- 1992-03-24 AT AT92907877T patent/ATE137671T1/de active
- 1992-03-24 JP JP50719592A patent/JP3400999B2/ja not_active Expired - Lifetime
- 1992-03-24 ES ES95111178T patent/ES2168322T3/es not_active Expired - Lifetime
- 1992-03-24 EP EP92907877A patent/EP0580648B1/en not_active Expired - Lifetime
- 1992-03-24 ES ES92907877T patent/ES2086733T3/es not_active Expired - Lifetime
- 1992-04-10 IS IS3834A patent/IS3834A/is unknown
- 1992-04-10 IE IE114492A patent/IE921144A1/en not_active IP Right Cessation
-
1993
- 1993-10-06 NO NO19933575A patent/NO311867B1/no not_active IP Right Cessation
- 1993-10-08 FI FI934429A patent/FI105388B/fi not_active IP Right Cessation
- 1993-10-08 BG BG98147A patent/BG61474B1/bg unknown
-
1994
- 1994-11-17 EE EE9400417A patent/EE02970B1/xx unknown
-
1995
- 1995-06-07 US US08/479,494 patent/US5562923A/en not_active Expired - Lifetime
-
1996
- 1996-07-23 GR GR960401961T patent/GR3020602T3/el unknown
-
1997
- 1997-04-24 HK HK52497A patent/HK52497A/xx not_active IP Right Cessation
-
2002
- 2002-11-29 JP JP2002347368A patent/JP2003155228A/ja active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO311867B1 (no) | Fremgangsmåte for kondisjonering av vannopplöselige stoffer | |
| RU93058260A (ru) | Способ получения водорастворимых микронизированных веществ | |
| CA2022104C (en) | Supercritical fluid and near critical gas extraction of organic solvents from formed articles | |
| CA2093321A1 (en) | Transdermal device | |
| KR0167122B1 (ko) | 저농약 함량의 식물 활성 성분 농축물의 제조 방법 | |
| Smith et al. | Supercritical fluid extraction and gas chromatographic determination of the sesquiterpene lactone parthenolide in the medicinal herb feverfew (Tanacetum parthenium) | |
| JPH09508695A (ja) | 溶液から材料を乾燥する方法 | |
| NO180801C (no) | Fremgangsmåte til fremstilling av et frysetörket preparat | |
| KR910000709A (ko) | 온단세트론 염산염 이수화물 결정의 입도 감소법 | |
| Smolarz | Comparative study on the free flavonoid aglycones in herbs of different species of Polygonum L | |
| IE36411L (en) | Tobacco aroma substances. | |
| RU2006126051A (ru) | Способы получения партии активного фармацевтического ингредиента, контейнер, содержащий криогранулы аллергенного продукта, и криогранула аллергенного продукта | |
| KR960000427B1 (ko) | 경질 피복 물질에 캡슐화시키기에 특히 적합한 약제 및 이의 제조 방법 | |
| ATE86477T1 (de) | Galenische form eines trockenextraktes von pflanzen. | |
| ES2061713T3 (es) | Nuevas formas galenicas de corticoides para administracion por via per- y sublingual y su procedimiento de preparacion. | |
| Erazo et al. | Phytochemical and biological study of Radal Lomatia hirsuta (Proteaceae) | |
| Kauffman et al. | Improved apparatus for continuous column chromatography | |
| CN108782885B (zh) | 一种保留药效活性成分的三叶青茶加工方法 | |
| EP0932409B1 (en) | A method for producing an extract from valeriana officinalis containing high levels of valerenic acid | |
| KR940002798B1 (ko) | 플라본배당체의 추출방법과 그 장치 | |
| RU99117036A (ru) | Способ получения сухой комбинированной сибиреязвенной вакцины | |
| JPS6146202A (ja) | 難乾燥性物質または熱感受性物質の乾燥方法 | |
| CN1215057C (zh) | 用冷冻干燥方式从中药提取液中分离回收二甲基亚砜的方法 | |
| JP4313546B2 (ja) | トレハロース無水和物の生成方法 | |
| Rice et al. | Freeze-drying for electron microscopy |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK1K | Patent expired |